Pharmacy, Pharmaceutical Sciences, and Administration at University of Connecticut

UConn's pharmacy program illustrates why looking beyond the first year matters tremendously. While national peer programs suggest initial earnings around $49,000—modest for someone with $27,000 in debt—the picture transforms by year four, when the median reaches $113,478. This trajectory likely reflects graduates completing additional clinical training or advanced degrees common in pharmacy careers, where entry-level positions give way to full pharmacist roles.

That debt level merits attention. At $27,000, it matches the state median but sits above the national benchmark of $23,413. The estimated 0.55 debt-to-earnings ratio based on first-year figures looks reasonable on paper, though in practice, graduates may face tighter budgets during those initial years while completing residencies or additional certifications. The 5th percentile national debt ranking confirms this program loads students with relatively modest borrowing compared to pharmacy programs elsewhere.

The key question is whether your child is committed to the full pharmacy career path. If they're pursuing a PharmD or planning for clinical pharmacy work, that four-year earnings figure suggests strong returns that will make the debt manageable. But if they're uncertain about the field or considering stopping at the bachelor's level, those estimated early earnings based on peer programs could mean several lean years before the investment pays off.